← Open Payments lookup

TITILOPE OMISAKIN: Open Payments

NPI 1407536345 · PLYMOUTH, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$146 in 9 payments from 8 companies in 2025. Trend: 2023 $136 · 2024 $233 · 2025 $146

Food & beverage: $146
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.2$35
Supernus Pharmaceuticals, Inc.1$25
Collegium Pharmaceutical, Inc.1$15
ABBVIE INC.1$15
Lundbeck LLC1$14
Takeda Pharmaceuticals U.S.A., Inc.1$14
Almatica Pharma LLC1$14
Sage Therapeutics, LLC1$13

Products named: FANAPT, Qelbree, Jornay PM, VRAYLAR, REXULTI, TRINTELLIX, LOREEV XR, ZURZUVAE.

Industry payments across MN — which companies pay providers there.